KPV (Lysine–Proline–Valine) is a bioactive tripeptide derived from Alpha-Melanocyte Stimulating Hormone (α-MSH), recognised for its powerful anti-inflammatory and immunomodulatory properties. Unlike traditional anti-inflammatory agents, KPV helps regulate excessive inflammatory responses without broadly suppressing immune function. It has gained increasing interest for supporting gut health, tissue recovery, skin repair, and exercise recovery by reducing inflammatory signalling at the cellular level. KPV works by modulating key inflammatory pathways involved in chronic inflammation and tissue damage. It helps suppress the production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, while supporting the body's natural healing response. The peptide also helps maintain the integrity of the intestinal barrier, supports healthy immune regulation, and promotes tissue regeneration. By reducing excessive inflammation without compromising normal immune defence, KPV may assist recovery from intense physical training while supporting gastrointestinal and skin health. KPV is commonly incorporated into research and wellness protocols for: Dosage should be individualized according to treatment goals and administered under the supervision of a qualified healthcare professional. Store lyophilized vials at 2–8°C, protected from heat, moisture, and direct sunlight. After reconstitution, refrigerate immediately, avoid freezing, and use according to aseptic handling recommendations. KPV is generally well tolerated in available research. Mild injection-site irritation, redness, temporary discomfort, headache, or nausea may occasionally occur. Since long-term human safety data remain limited, discontinue use if unexpected adverse reactions develop and consult a qualified healthcare professional. KPV should only be used under professional medical supervision. Individuals with autoimmune disorders, chronic inflammatory diseases, gastrointestinal conditions, or those who are pregnant or breastfeeding should consult a healthcare professional before use. Long-term clinical data are still evolving, and appropriate medical monitoring is recommended. KPV is commonly incorporated into recovery-focused protocols and may be combined with regenerative peptides such as BPC-157 or TB-500, as well as growth hormone secretagogues and gut-support protocols under appropriate professional guidance. Stacking strategies should always be individualized based on recovery goals and overall health status. The information provided is for educational purposes only and is not intended as medical advice. Use KPV (α-MSH Fragment Tripeptide) only under professional supervision. Product images are for illustration purposes only and may differ from the actual product. Packaging and labeling are subject to change without prior notice.KPV
KPV (α-MSH Frag Tripeptide): 15 mg
How It Works
Frequently Used For
Dosage & Storage
Possible Side Effects
Precautions
Stacking Compatibility
Disclaimer